BerandaONC • TSE
add
Oncolytics Biotech Inc
Tutup sebelumnya
$0,78
Rentang hari
$0,75 - $0,78
Rentang tahun
$0,67 - $2,08
Kapitalisasi pasar
60,02Â jt CAD
Volume Rata-Rata
57,11Â rb
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 8,44Â jt | -4,66% |
Laba bersih | -8,02Â jt | -103,01% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,10 | 9,91% |
EBITDA | -8,43Â jt | 4,56% |
Tarif pajak efektif | -0,29% | — |
Neraca
Total aset
Total liabilitas
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 15,94Â jt | -54,34% |
Total aset | 20,19Â jt | -48,00% |
Total liabilitas | 14,20Â jt | 26,18% |
Total ekuitas | 5,98 jt | — |
Saham yang beredar | 86,42 jt | — |
Harga terhadap nilai buku | 11,14 | — |
Tingkat pengembalian aset | -94,91% | — |
Tingkat pengembalian modal | -245,72% | — |
Arus Kas
Perubahan kas bersih
| (CAD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -8,02Â jt | -103,01% |
Kas dari operasi | -7,85Â jt | -28,12% |
Kas dari investasi | -6,00Â rb | -100,00% |
Kas dari pembiayaan | 3,34Â jt | 91,68% |
Perubahan kas bersih | -3,66Â jt | 27,88% |
Arus kas bebas | -4,62Â jt | 44,28% |
Tentang
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Didirikan
1998
Kantor pusat
Karyawan
28
